Stocks
Novartis (NVS) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 62.5% | 31.6% | 28.4% | 31.6% | 39.2% | 40.1% | ||
| Changes by years, y/y, % | +30pp | -31pp | -3pp | +3pp | +8pp | -0.9% | |||
Novartis. EBITDA margin, %
Novartis. EBITDA margin, changes, pp
Novartis (NVS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 40.4% | 35.7% | 39.7% | 42.0% | 42.7% | 40.1% | |
| Changes by years, y/y, % | +8pp | +6pp | +2pp | +7pp | +2pp | |||
| Changes by quarters, q/q, % | +6pp | -5pp | +4pp | +2pp | +1pp | |||
